Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply

Walenta, 2002, Metabolic mapping with bioluminescence: basic and clinical relevance, Biomol. Eng., 18, 249, 10.1016/S1389-0344(01)00107-1 Weindruch, 1988 Rous, 1914, The influence of diet on transplanted and spontaneous tumors, J. Exp. Med., 20, 433, 10.1084/jem.20.5.433 Mukherjee, 2004, Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors, Clin. Cancer Res., 10, 5622, 10.1158/1078-0432.CCR-04-0308 Warburg, 1956, On the origin of cancer cells, Science, 123, 309, 10.1126/science.123.3191.309 Gatenby, 2004, Why do cancers have high aerobic glycolysis?, Nat. Rev. Cancer, 4, 891, 10.1038/nrc1478 Kelloff, 2005, Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development, Clin. Cancer Res., 11, 2785, 10.1158/1078-0432.CCR-04-2626 Semenza, 1994, Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1, J. Biol. Chem., 269, 23757, 10.1016/S0021-9258(17)31580-6 Kim, 2004, Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays, Mol. Cell Biol., 24, 5923, 10.1128/MCB.24.13.5923-5936.2004 Kole, 1991, Regulation of 6-phosphofructo-1-kinase activity in ras-transformed rat-1 fibroblasts, Arch. Biochem. Biophys., 286, 586, 10.1016/0003-9861(91)90084-V Dang, 1999, Oncogenic alterations of metabolism, Trends. Biochem. Sci., 24, 68, 10.1016/S0968-0004(98)01344-9 Robey, 2009, Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis, Semin. Cancer Biol., 19, 25, 10.1016/j.semcancer.2008.11.010 DeBerardinis, 2008, The biology of cancer: metabolic reprogramming fuels cell growth and proliferation, Cell Metab., 7, 11, 10.1016/j.cmet.2007.10.002 Montagut, 2009, Targeting the RAF-MEK-ERK pathway in cancer therapy, Cancer Lett., 10.1016/j.canlet.2009.01.022 Zwerschke, 1999, Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein, Proc. Natl. Acad. Sci. USA, 96, 1291, 10.1073/pnas.96.4.1291 Mazurek, 2001, Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7, Oncogene, 20, 6891, 10.1038/sj.onc.1204792 Gregory, 1976, Glycolytic enzyme activities in murine sarcoma virus-transformed cultures of Balb 3T3. The role of culture density, Arch, Biochem. Biophys., 175, 644, 10.1016/0003-9861(76)90555-5 Ramanathan, 2005, Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements, Proc. Natl. Acad. Sci. U. S. A., 102, 5992, 10.1073/pnas.0502267102 Blum, 2005, Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death, Cancer Res., 65, 999, 10.1158/0008-5472.999.65.3 Vizan, 2005, K-ras codon-specific mutations produce distinctive metabolic phenotypes in NIH3T3 mice fibroblasts, Cancer Res., 65, 5512, 10.1158/0008-5472.CAN-05-0074 Chesney, 1999, An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect, Proc. Natl. Acad. Sci. U. S. A., 96, 3047, 10.1073/pnas.96.6.3047 Tong, 2009, The molecular determinants of de novo nucleotide biosynthesis in cancer cells, Curr. Opin. Genet. Dev., 19, 32, 10.1016/j.gde.2009.01.002 Dang, 2008, The interplay between MYC and HIF in cancer, Nat. Rev. Cancer, 8, 51, 10.1038/nrc2274 Minchenko, 2002, Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect, J. Biol. Chem., 277, 6183, 10.1074/jbc.M110978200 Carmeliet, 1998, Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis, Nature, 394, 485, 10.1038/28867 Shim, 1998, A unique glucose-dependent apoptotic pathway induced by c-Myc, Proc. Natl. Acad. Sci. U. S. A., 95, 1511, 10.1073/pnas.95.4.1511 Guertin, 2004, Growth control through the mTOR network, 193 Loewith, 2004, TOR signaling in yeast: temporal and spatial control of cell growth, 139 Zwerschke, 2000, Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins, Adv. Cancer Res., 78, 1 Mazurek, 2005, Pyruvate kinase type M2 and its role in tumor growth and spreading, Semin. Cancer Biol., 15, 300, 10.1016/j.semcancer.2005.04.009 Christofk, 2008, The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumor growth, Nature, 452, 230, 10.1038/nature06734 Christofk, 2008, Pyruvate kinase M2 is a phosphotyrosine-binding protein, Nature, 452, 181, 10.1038/nature06667 Mazurek, 2007, U.R. Rapp UR, Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism, Anticancer Res., 27, 3963 Spoden, 2008, Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation, Int. J. Cancer, 123, 312, 10.1002/ijc.23512 Johnson, 1995, Methods for studying cell death and viability in primary neuronal cultures, Meth. Cell Biol., 46, 243, 10.1016/S0091-679X(08)61932-9 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Berridge, 1993, Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction, Arch. Biochem. Biophys., 303, 474, 10.1006/abbi.1993.1311 Valentinis, 2000, Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells, J. Biol. Chem., 275, 25451, 10.1074/jbc.M002271200 Mazurek, 2001, Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic–enzyme complex, Biochem. J., 356, 247, 10.1042/bj3560247 Tian, 1999, Importance of glucose-6-phosphate dehydrogenase activity in cell death, Am. J. Physiol., 276, C1121, 10.1152/ajpcell.1999.276.5.C1121 Hammerman, 2004, Beginnings of a signal-transduction pathway for bioenergetic control of cell survival, Trends. Biochem. Sci., 29, 586, 10.1016/j.tibs.2004.09.008 Reitzer, 1979, Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells, J. Biol. Chem., 254, 2669, 10.1016/S0021-9258(17)30124-2 Rossignol, 2004, Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells, Cancer Res., 64, 985, 10.1158/0008-5472.CAN-03-1101 Muñoz-Pinedo, 2003, Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical procaspase-8 processing, J. Biol. Chem., 278, 12759, 10.1074/jbc.M212392200 Plas, 2005, Akt-dependent transformation: there is more to growth than just surviving, Oncogene, 24, 7435, 10.1038/sj.onc.1209097 Matsunaga, 2008, l-Xylulose reductase is involved in 9,10-phenanthrenequinone-induced apoptosis in human T lymphoma cells, Free Radic. Biol. Med., 44, 1191, 10.1016/j.freeradbiomed.2007.12.024 Yoo, 2004, Decreased pyruvate kinase M2 activity linked to cisplatin resistance in gastric carcinoma cell lines, Int. J. Cancer, 108, 532, 10.1002/ijc.11604 Tian, 1998, Importance of glucose-6-phosphate dehydrogenase activity for cell growth, J. Biol. Chem., 273, 10609, 10.1074/jbc.273.17.10609 Edinger, 2002, Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake, Mol. Biol. Cell, 13, 2276, 10.1091/mbc.01-12-0584 Plas, 2001, Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology, J. Biol. Chem., 276, 12041, 10.1074/jbc.M010551200 Gottlob, 2001, Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase, Genes Dev., 15, 1406, 10.1101/gad.889901 Porstmann, 2008, SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth, Cell Metab., 8, 224, 10.1016/j.cmet.2008.07.007 Park, 2006, Cellular redox state predicts in vitro corneal endothelial cell proliferation capacity, Exp. Eye Res., 83, 903, 10.1016/j.exer.2006.04.015 Dames, 2005, The solution structure of the FATC domain of the protein kinase target of rapamycin suggests a role for redox-dependent structural and cellular stability, J. Biol. Chem., 280, 20558, 10.1074/jbc.M501116200 Sarbassov, 2005, Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex, J. Biol. Chem., 280, 39505, 10.1074/jbc.M506096200